Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Olafsson, Ingvar Hakon
Ghatan, Per Hamid
Bro Skejo, Hanne Pernille
Svensson, Mikael A
MetadataShow full item record
CitationActa Neurochir (Wien). 2011, 153(1):90-100
AbstractOBJECT: Complement activation has been suggested to play a role in the development of secondary injuries following traumatic brain injury (TBI). The present study was initiated in order to analyze complement activation in relation to the primary brain injury and to secondary insults, frequently occurring following TBI. METHODS: Twenty patients suffering from severe TBI (Glasgow coma score ≤ 8) were included in the study. The "membrane attack complex," C5b9, which is the cytolytic end product of the complement system was analyzed in cerebrospinal fluid (CSF). The degree of brain tissue damage was assessed using the release of S100B and neuron-specific enolase (NSE) to the CSF and blood. The blood-brain barrier was assessed using the CSF/serum quotient of albumin (Q (A)). RESULTS: Following impact, initial peaks (0-48 h) of C5b9, S100B, and NSE with a concomitant loss of integrity of the blood-brain barrier were observed. Secondary insults at the intensive care unit were monitored. Severe secondary insults were paralleled by a more pronounced complement activation (C5b9 in CSF) as well as increased levels of S100B (measured in CSF), but not with NSE. CONCLUSION: This human study indicates that complement activation in the brain is triggered not only by the impact of trauma per se but also by the amount of secondary insults that frequently occur at the scene of accident as well as during treatment in the neurointensive care unit. Complement activation and in particular the end product C5b9 may in turn contribute to additional secondary brain injuries by its membrane destructive properties.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to Acta neurochirurgica
- Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
- Authors: Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM
- Issue date: 2002 Feb
- Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
- Authors: Stein DM, Kufera JA, Lindell A, Murdock KR, Menaker J, Bochicchio GV, Aarabi B, Scalea TM
- Issue date: 2011 Apr
- Activin a release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury.
- Authors: Phillips DJ, Nguyen P, Adamides AA, Bye N, Rosenfeld JV, Kossmann T, Vallance S, Murray L, Morganti-Kossmann MC
- Issue date: 2006 Sep
- Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
- Authors: Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, D'Avila TT, Souza DO, Portela LV, Stefani MA
- Issue date: 2011 Jun
- Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
- Authors: Geyer C, Ulrich A, Gräfe G, Stach B, Till H
- Issue date: 2009 Oct